2326 - 2350 of 9150 Results
Title
Year
-
OPENTitle: Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273RJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 146Issue #:Start Page: 105079End Page: 105079Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105079Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105079Citation Count: 8
-
OPENTitle: Variable number tandem repeats – Their emerging role in sickness and healthJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 246Issue #: 12Start Page: 1368End Page: 1376Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1177/15353702211003511Best OA location URL: https://doi.org/10.1177/15353702211003511Citation Count: 28
-
OPENTitle: The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 35Issue #: 7Start Page: 691End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000760Best OA location URL: https://doi.org/10.1037/neu0000760Citation Count: 3
- Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.2022RESTRICTEDTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Citation Count: 5
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
-
OPENTitle: Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 796End Page: 805Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29375Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29375Citation Count: 23
-
RESTRICTEDTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Best OA location URL: http://doi.org/10.1002/mds.26251Citation Count: 116
- A trio has turned into a quartet: DJ-1 interacts with the IP3R-Grp75-VDAC complex to control ER-mitochondria interaction2020RESTRICTEDTitle: A trio has turned into a quartet: DJ-1 interacts with the IP3R-Grp75-VDAC complex to control ER-mitochondria interactionJournal Name: Cell CalciumPublisher: Elsevier BVVol: 87Issue #:Start Page: 102186End Page: 102186Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ceca.2020.102186Citation Count: 71
-
OPENTitle: New insights from a Malaysian real-world deep brain stimulation cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 1Start Page: 189End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241297715Best OA location URL: https://doi.org/10.1177/1877718x241297715Citation Count: 5
-
OPENTitle: Defining Quality of Life: The Perspective of People Living with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 13Issue #: 6Start Page: 1446End Page: 1451Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.70517Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70517Citation Count: 0
-
OPENTitle: Genetic, Structural, and Functional Evidence Link TMEM175 to SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 87Issue #: 1Start Page: 139End Page: 153Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25629Best OA location URL: http://hdl.handle.net/11380/1205909Citation Count: 107
- Normative morphometric data for cerebral cortical areas over the lifetime of the adult human brain2017RESTRICTEDTitle: Normative morphometric data for cerebral cortical areas over the lifetime of the adult human brainJournal Name: NeuroImagePublisher: Elsevier BVVol: 156Issue #:Start Page: 315End Page: 339Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.019Citation Count: 85
-
OPENTitle: Cryogel microcarriers for sustained local delivery of growth factors to the brainJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 369Issue #:Start Page: 404End Page: 419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jconrel.2024.03.023Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0168365924001755-ga1_lrg.jpgCitation Count: 14
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial2019RESTRICTEDTitle: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 145End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8Citation Count: 122
- Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson’s Disease at Fall-Risk2023RESTRICTEDTitle: Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson’s Disease at Fall-RiskJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 817Issue #:Start Page: 137517End Page: 137517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2023.137517Citation Count: 6
-
OPENTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3589103Citation Count: 47
-
OPENTitle: A unifying model for the role of the ATG8 system in autophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 135Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/jcs.258997Best OA location URL: https://doi.org/10.1242/jcs.258997Citation Count: 28
- Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril Binding2019RESTRICTEDTitle: Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril BindingJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 84Issue #: 7Start Page: 3887End Page: 3903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.joc.8b03015Citation Count: 22
-
OPENTitle: The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy modelsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 123Issue #: 12Start Page: e2517886123End Page: e2517886123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2517886123Best OA location URL: https://doi.org/10.1073/pnas.2517886123Citation Count: 0
-
OPENTitle: Deep learning-derived arterial input function for dynamic brain PETJournal Name: NeuroImagePublisher: Elsevier BVVol: 324Issue #:Start Page: 121609End Page: 121609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2025.121609Best OA location URL: https://doi.org/10.1016/j.neuroimage.2025.121609Citation Count: 2
- A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regions2024RESTRICTEDTitle: A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 9Start Page: 859End Page: 860Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00313-2Citation Count: 4
-
OPENTitle: Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 723End Page: 735Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261431204Best OA location URL: https://doi.org/10.1177/1877718x261431204Citation Count: 0
-
OPENTitle: Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 264End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28837Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8840955Citation Count: 27
- Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation Carriers2021OPENTitle: Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 629End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940604Citation Count: 8
- Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease2021OPENTitle: Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 334End Page: 342Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28850Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8922308Citation Count: 42
